日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

糖基化LGALS3BP由膀胱癌细胞大量分泌,是一种新型泌尿系统疾病生物标志物。

Pece, Asia; Lovato, Giulio; Cela, Ilaria; Mercatelli, Arianna; Ferro, Benedetta; Nikkola, Jussi; Pagotto, Sara; Grottola, Tommaso; De Laurenzi, Vincenzo; Cicchetti, Rossella; Marchetti, Antonio; Schips, Luigi; Lattanzio, Rossano; Iacobelli, Stefano; Capone, Emily; Black, Peter; Daugaard, Mads; Marchioni, Michele; Sala, Gianluca

LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth.

LGALS3BP 抗体药物偶联物可增强肿瘤浸润淋巴细胞,并与免疫疗法协同作用,抑制神经母细胞瘤的生长

Cela Ilaria, Capone Emily, Pece Asia, Lovato Giulio, Simeone Pasquale, Colasante Martina, Lamolinara Alessia, Piro Anna, Iezzi Manuela, Lanuti Paola, De Laurenzi Vincenzo, Ippoliti Rodolfo, Iacobelli Stefano, Sala Gianluca

Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S‑Methyl-DM4.

利用新型 HPLC-DAD 方法评价抗体-药物偶联物在肿瘤特异性检测 DM4 和 S'甲基-DM4 中的性能。

Lovato Giulio, Perrucci Miryam, Cela Ilaria, Lamolinara Alessia, Mercatelli Arianna, De Laurenzi Vincenzo, Capone Emily, Locatelli Marcello, Sala Gianluca